Inventor · disambiguated record
Steven Shak
Also filed as: SHAK STEVEN
32 granted patents·26 pending applications·942 citations·filing 1994–2024
97Inventor score
Top patents by PatentIndex Score
58 records- 0198US7930104B2Predicting response to chemotherapy using gene expression markersGENOMIC HEALTH INC·Filed 2005·Granted Apr 19, 2011·91 cites·24 claims
- 0298US6627196B1Dosages for treatment with anti-ErbB2 antibodiesGENENTECH INC·Filed 2000·Granted Sep 30, 2003·209 cites·33 claims
- 0396US7723033B2Prediction of likelihood of cancer recurrenceGENOMIC HEALTH INC·Filed 2006·Granted May 25, 2010·28 cites·12 claims
- 0496US7371379B2Dosages for treatment with anti-ErbB2 antibodiesGENENTECH INC·Filed 2003·Granted May 13, 2008·86 cites·40 claims
- 0595US10280228B2Treatment with anti-ErbB2 antibodiesGENENTECH INC·Filed 2018·Granted May 7, 2019·16 cites·9 claims
- 0695US7871769B2Gene expression markers for predicting response to chemotherapyGENOMIC HEALTH INC·Filed 2005·Granted Jan 18, 2011·47 cites·22 claims
- 0795US7056674B2Prediction of likelihood of cancer recurrenceNSABP FOUNDATION INC·Filed 2004·Granted Jun 6, 2006·148 cites·10 claims
- 0894US8034565B2Gene expression markers for breast cancer prognosisGENOMIC HEALTH INC·Filed 2009·Granted Oct 11, 2011·15 cites·16 claims
- 0994US7939261B2Expression profile algorithm and test for cancer prognosisGENOMIC HEALTH INC·Filed 2009·Granted May 10, 2011·25 cites·29 claims
- 1094US7892549B2Treatment with anti-ErbB2 antibodiesGENENTECH INC·Filed 2003·Granted Feb 22, 2011·60 cites·17 claims
- 1194US7622251B2Molecular indicators of breast cancer prognosis and prediction of treatment responseGENOMIC HEALTH INC·Filed 2005·Granted Nov 24, 2009·31 cites·12 claims
- 1293US10160811B2Treatment with anti-ErbB2 antibodiesGENENTECH INC·Filed 2013·Granted Dec 25, 2018·17 cites·12 claims
- 1393US6348343B2Human DNase I variantsGENENTECH INC·Filed 2001·Granted Feb 19, 2002·48 cites·21 claims
- 1492US7526387B2Expression profile algorithm and test for cancer prognosisGENOMIC HEALTH INC·Filed 2004·Granted Apr 28, 2009·47 cites·36 claims
- 1591US8148076B2Gene expression profiling of EGFR positive cancerBAKER JOFFRE B·Filed 2011·Granted Apr 3, 2012·10 cites·8 claims
- 1690US7297526B2Human DNaseGENENTECH INC·Filed 2004·Granted Nov 20, 2007·18 cites·12 claims
- 1788US8868352B2Predicting response to chemotherapy using gene expression markersBAKER JOFFRE B·Filed 2011·Granted Oct 21, 2014·10 cites·21 claims
- 1886US12412642B2Method to use gene expression to determine likelihood of clinical outcome of renal cancerGENOMIC HEALTH INC·Filed 2023·Granted Sep 9, 2025·0 cites·20 claims
- 1986US10260104B2Method for using gene expression to determine prognosis of prostate cancerGENOMIC HEALTH INC·Filed 2015·Granted Apr 16, 2019·2 cites·11 claims
- 2086US9551034B2Method to use gene expression to determine likelihood of clinical outcome of renal cancerCOWENS WAYNE·Filed 2011·Granted Jan 24, 2017·5 cites·12 claims
- 2185US2025129432A1Method for Using Gene Expression to Determine Prognosis of Prostate CancerMDXHEALTH SA·Filed 2024·Application pending·0 cites
- 2278US2022396842A1Method for using gene expression to determine prognosis of prostate cancerMDXHEALTH SA·Filed 2022·Application pending·0 cites
- 2375US10181008B2Gene expression profile algorithm for calculating a recurrence score for a patient with kidney cancerGENOMIC HEALTH INC·Filed 2014·Granted Jan 15, 2019·1 cites·17 claims
- 2475US9944990B2Gene expression markers for breast cancer prognosisGENOMIC HEALTH INC·Filed 2014·Granted Apr 17, 2018·0 cites·6 claims
- 2574US11776664B2Method to use gene expression to determine likelihood of clinical outcome of renal cancerGENOMIC HEALTH INC·Filed 2020·Granted Oct 3, 2023·0 cites·20 claims
- 2673US11220715B2Gene expression markers for breast cancer prognosisGENOMIC HEALTH INC·Filed 2018·Granted Jan 11, 2022·0 cites·4 claims
- 2772US2019249260A1Method for Using Gene Expression to Determine Prognosis of Prostate CancerGENOMIC HEALTH INC·Filed 2019·Application pending·0 cites
- 2871US10619215B2Prediction of likelihood of cancer recurrenceGENOMIC HEALTH INC·Filed 2017·Granted Apr 14, 2020·0 cites·11 claims
- 2971US2020299781A1Prediction of Likelihood of Cancer RecurrenceGENOMIC HEALTH INC·Filed 2020·Application pending·0 cites
- 3070US2010184041A1Molecular Indicators of Breast Cancer Prognosis and Prediction of Treatment ResponseBAKER JOFFRE B·Filed 2009·Application pending·0 cites
- 3169US9605318B2Gene expression markers for predicting response to chemotherapyBAKER JOFFRE B·Filed 2010·Granted Mar 28, 2017·1 cites·18 claims
- 3269US2020255911A1Method for Using Gene Expression to Determine Prognosis of Prostate CancerGENOMIC HEALTH INC·Filed 2020·Application pending·0 cites
- 3368US2019240185A1TREATMENT WITH ANTI ErbB2 ANTIBODIESGENENTECH INC·Filed 2019·Application pending·0 cites
- 3467US8273534B2Predictors of patient response to treatment with EGF receptor inhibitorsBAKER JOFFRE B·Filed 2009·Granted Sep 25, 2012·0 cites·12 claims
- 3567US2019055317A1TREATMENT WITH ANTI-ErbB2 ANTIBODIESGENENTECH INC·Filed 2018·Application pending·0 cites
- 3666US11551782B2Gene expression profile algorithm for calculating a recurrence score for a patient with kidney cancerGENOMIC HEALTH INC·Filed 2020·Granted Jan 10, 2023·0 cites·19 claims
- 3764US10892038B2Method to use gene expression to determine likelihood of clinical outcome of renal cancerGENOMIC HEALTH INC·Filed 2016·Granted Jan 12, 2021·0 cites·22 claims
- 3864US2005164218A1Gene expression markers for response to EGFR inhibitor drugsFiled 2004·Application pending·0 cites
- 3964US2014303002A1Gene Expression Profile Algorithm and Test for Determining Prognosis of Prostate CancerGENOMIC HEALTH INC·Filed 2014·Application pending·0 cites
- 4064US2008176229A1Gene Expression Markers for Response to EGFR Inhibitor DrugsAGUS DAVID·Filed 2007·Application pending·0 cites
- 4163US2004157255A1Gene expression markers for response to EGFR inhibitor drugsFiled 2004·Application pending·0 cites
- 4263US2008026426A1Anti-infective therapyGENENTECH INC·Filed 2007·Application pending·0 cites
- 4363US2009125247A1Gene expression markers of recurrence risk in cancer patients after chemotherapyBAKER JOFFRE·Filed 2008·Application pending·0 cites
- 4461US2006210561A1Dosages for treatment with anti-EGFR antibodiesGENENTECH INC·Filed 2006·Application pending·0 cites
- 4561US2010267032A1Prediction of Likelihood of Cancer RecurrenceBAKER JOFFRE B·Filed 2010·Application pending·0 cites
- 4659US5876970ASurfactant compositions and methodsBYK GULDEN LOMBERG CHEM FAB·Filed 1994·Granted Mar 2, 1999·26 cites·6 claims
- 4759US2015079591A1Predicting response to chemotherapy using gene expression markersGENOMIC HEALTH INC·Filed 2014·Application pending·0 cites
- 4859US2013149299A1Dosages for treatment with anti-egfr antibodiesBAUGHMAN SHARON A·Filed 2012·Application pending·0 cites
- 4958US11011252B1Gene expression profile algorithm and test for determining prognosis of prostate cancerGENOMIC HEALTH INC·Filed 2017·Granted May 18, 2021·0 cites·13 claims
- 5058US2019095575A1Gene Expression Profile Algorithm for Calculating a Recurrence Score for a Patient with Kidney CancerGENOMIC HEALTH INC·Filed 2018·Application pending·0 cites
Showing the top 50 of 58 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →